[Chemotherapy of leprosy--effect of the anti-leprotic agent on the growth of acid-fast bacilli in cutaneous and mucous tissue].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000302:isolation & purification; D009297:Nasal Mucosa / Q000382:microbiology*; D009821:Oils / Q000627:therapeutic use; D012737:Sex Factors; D012867:Skin / Q000382:microbiology*; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use; D013441:Sulfinic Acids / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use
D000814:Aniline Compounds; D009821:Oils; D013441:Sulfinic Acids; D013450:Sulfones; D013844:Thiazoles; D013882:Thiosemicarbazones; D003622:Dapsone; D013421:Sulfamethoxypyridazine